LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price on Nov 20, 2025

LAVA Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for LAVA Therapeutics stock had an average target of $1.58, with a low estimate of $1.24 and a high estimate of $2.00.

Price Target: $1.58 (-9.20%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$1.24$1.58n/a$2.00
Change-28.74%-9.20%n/a+14.94%

Analyst Ratings

The average analyst rating for LAVA Therapeutics stock from 4 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
from 11.98M
Revenue Next Year
n/a
EPS This Year
-0.86
from -0.94
EPS Next Year
-0.51
from -0.86
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
EPS
-39.90-2.14-1.23-1.57-0.94-0.86-0.51
No. Analysts
-----44

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-0.88-0.49
Avg-0.86-0.51
Low-0.82-0.52

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--